Managing Director, International for Canada,
Latin America and Asia Pacific
Isabelle Levy-Unger is the Managing Director for the Bioventus International Business in Canada, Latin America and Asia Pacific. She has been with Bioventus since April 2013 and from October 2014 until May 2014, served as an Interim Managing Director of the international business. Prior to that, Isabelle served as the company’s Director of International Commercial Operations for the Americas and as a Director of Operational Excellence. Prior to joining Bioventus, Isabelle worked for 13 years at Grifols, Inc., which was formerly known as Talecris Biotherapeutics and Bayer Biological during much of that period. Initially an employee with Bayer Biological, she served in global sales and marketing roles from 1999 to 2004 when she was appointed to lead the transition activities for the divestiture of the business from Bayer to Talecris which concluded in 2005. At Talecris, Isabelle served as Director of European Commercial Operations and later as Senior Director of International Operations before being promoted to Head of Sales, International in January of 2010. In 2011, Grifols acquired Talecris and Isabelle continued to lead sales into 2012. Previously, Isabelle held sales and marketing roles with Reichhold Chemicals.
Isabelle’s native language is French, but she is also fluent in English and Spanish. She holds a postgraduate degree in negotiation and international business from the University of Paris, La Sorbonne; a master’s degree in international business, a Bachelor of Arts in marketing, and a baccalaureate in economics the University of Le Havre, France. In addition, she has studied management and marketing, communications and English and Spanish at Appalachian State University in Boone, NC.